Fondazione IRCCS Policlinico San Matteo di Pavia: Immunoglobulin Light-chain Amyloidosis trials
The registry lists 14 Immunoglobulin Light-chain Amyloidosis studies with Fondazione IRCCS Policlinico San Matteo di Pavia as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 2 6Phase 3 1No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMSRecruitingNCT07448935
- Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and TreatmentRecruitingNCT07448779
- Promoting Diagnosis and Management of AL in Italy (ProDigALIty)RecruitingNCT06383143
- A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)RecruitingNCT06205953
- The Italian Transthyretin Amyloidosis Web-NetworkRecruitingNCT05444920
- A Registry of AL Amyloidosis (ReAL)RecruitingNCT04839003
- Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug ResistanceCompletedNCT07585331
- Daratumumab and Pomalidomide in Previously Treated Patients With AL AmyloidosisTerminatedNCT04895917Phase 2
- Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL AmyloidosisCompletedNCT04392960Not applicable
- A Trial of Doxycycline vs. Standard Supportive Therapy in Newly-diagnosed Cardiac AL Amyloidosis Patients Undergoing Bortezomib-based TherapyTerminatedNCT03474458Phase 2/3
- High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal DiseaseWithdrawnNCT01531751Phase 2
- Epigallocatechingallate (EGCG) in Cardiac AL AmyloidosisTerminatedNCT01511263Phase 2
- Pomalidomide and Dexamethasone (PDex) in AL AmyloidosisCompletedNCT01510613Phase 2
- Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL AmyloidosisCompletedNCT00607581Phase 2